c-Met plays important roles in regulation of cell growth, survival, and metastasis.8 Abnormal activation of c-Met signaling pathway was detected in many malignant tumors, including gastric cancer, lung cancer, esophageal cancer, breast cancer, liver cancer, colon cancer, prostate cancer, pancreatic cancer, kidney cancer, ovarian cancer, glioma, melanoma, osteosarcoma, and various cancers. This evidence concerns the gene MET and Familial prostate cancer.